Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > This drop has no reason

<< Previous

Bullboard Posts

Next >>

Comment by Davidtepperss62on Jul 21, 2020 8:24pm

92 Views

Post# 31299313

RE:This drop has no reason

Sylvain123 wrote: Pas facile de comprendre ces soldes bon march.

Je garde ce titre, il n'y a aucune raison pour qu'il redescende.

The stock markets have become a jungle of aggressive, corrupt sharks of Day Traders manipulators and speculators who buy and sell on the same day for a small profit because they don't want to get stuck with a short-term stock. is made a real casino of gamblers who have mental problems for quick money. This is an aggressive PUMP and DUMP BASHERS game with corrupt liars.

<< Previous

Bullboard Posts

Next >>

How this junior is unlocking unprecedented potential in Alaska